Invention Grant
- Patent Title: Steatohepatitis-liver cancer model animal
-
Application No.: US14191942Application Date: 2014-02-27
-
Publication No.: US09596834B2Publication Date: 2017-03-21
- Inventor: Hiroyuki Yoneyama , Masato Fujii
- Applicant: STELIC INSTITUTE OF REGENERATIVE MEDICINE, STELIC INSTITUTE & CO.
- Applicant Address: JP Tokyo
- Assignee: Stelic Institute of Regenerative Medicine, Stelic Institute & Co.
- Current Assignee: Stelic Institute of Regenerative Medicine, Stelic Institute & Co.
- Current Assignee Address: JP Tokyo
- Agency: Bozicevic, Field & Francis LLP
- Agent Karl Bozicevic
- Main IPC: A01K67/00
- IPC: A01K67/00 ; A01K67/027

Abstract:
Fatty liver was induced by administering agents for inducing organ inflammation to experimental animals to evoke insulin resistance and by rearing them with high-fat diets. As a result, steatohepatitis was successfully induced in the animals. The animals show pathological findings similar to those of humans. By using these model animals, substances for treating or preventing diseases can be efficiently screened and the efficacy of medicinal substances can be effectively evaluated.
Public/Granted literature
- US20140178306A1 STEATOHEPATITIS-LIVER CANCER MODEL ANIMAL Public/Granted day:2014-06-26
Information query